Differentiation between valproate-induced anticonvulsant effect, teratogenicity and hepatotoxicity
- 1 June 1992
- journal article
- review article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 14 (3) , 101-107
- https://doi.org/10.1007/bf01962697
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Structure–Pharmacokinetic Relationships in a Series of Short Fatty Acid Amides that Possess Anticonvulsant ActivityJournal of Pharmaceutical Sciences, 1990
- Asymmetric synthesis and teratogenic activity of (R)- and (S)-2-ethylhexanoic acid, a metabolite of the plasticizer di-(2-ethylhexyl)phthalateLife Sciences, 1990
- Valproic Acid Prenatal ExposureClinical Pediatrics, 1989
- Valproic acid developmental toxicity and pharmacokinetics in the rhesus monkey: An interspecies comparisonTeratology, 1988
- Valproic acid-induced neural tube defects: Reduction by folinic acid in the mouseLife Sciences, 1987
- Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acidThe Journal of Pediatrics, 1986
- Acute anticonvulsant activity of structural analogues of valproic acid and changes in brain GABA and aspartate contentLife Sciences, 1983
- Sodium Valproate in the Induction of Unusual HepatotoxicityHepatology, 1982
- A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrationsLife Sciences, 1981
- Reye-like syndrome associated with valproic acid therapyThe Journal of Pediatrics, 1979